Compare · FIGS vs SILO
FIGS vs SILO
Side-by-side comparison of FIGS Inc. (FIGS) and Silo Pharma Inc. (SILO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FIGS and SILO operate in Apparel (Consumer Discretionary), so they compete in similar markets.
- FIGS is the larger of the two at $3.25B, about 1421.4x SILO ($2.3M).
- FIGS has been more active in the news (4 items in the past 4 weeks vs 3 for SILO).
- FIGS has more recent analyst coverage (25 ratings vs 0 for SILO).
- Company
- FIGS Inc.
- Silo Pharma Inc.
- Price
- $19.13-2.07%
- $1.21-0.82%
- Market cap
- $3.25B
- $2.3M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Apparel
- Apparel
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 4
- 3
- Recent ratings
- 25
- 0
FIGS
FIGS Inc.
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States. It designs and sells healthcare apparel and other non-scrub offerings, such as lab coats, under scrubs, outerwear, activewear, loungewear, compression socks footwear, masks, and face shields. The company markets and sells its products through its digital platform comprising website and mobile app. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California.
Latest FIGS
- FIGS Announces Date of Third Quarter 2026 Earnings Release, Conference Call and Webcast
- SEC Form 4 filed by FIGS Inc.
- SEC Form 4 filed by FIGS Inc.
- SEC Form 4 filed by FIGS Inc.
- FIGS Announces Participation in the Barclays 19th Annual Global Consumer Conference
- Executive Chairman Hasson Heather L. covered exercise/tax liability with 30,142 shares, decreasing direct ownership by 2% to 1,396,852 units (SEC Form 4) to cover withholding tax
- Chief Financial Officer Oughtred Sarah covered exercise/tax liability with 21,962 shares, decreasing direct ownership by 2% to 1,088,165 units (SEC Form 4) to cover withholding tax
- Telsey Advisory Group reiterated coverage on FIGS, Inc. with a new price target
- SEC Form 10-Q filed by FIGS Inc.
- FIGS Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Latest SILO
- SEC Form 8-K filed by Silo Pharma Inc.
- Silo Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Silo Pharma’s QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility
- Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio
- Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
- Silo Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
- Silo Pharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 10-Q filed by Silo Pharma Inc.
- Silo Pharma Granted European Patent Covering Novel PTSD Therapy